Related Experiment Video

Updated: Jun 3, 2026

Bioluminescent Bacterial Imaging In Vivo
05:06

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

Bacteria as vectors for gene therapy of cancer

Chwanrow K Baban1, Michelle Cronin, Deirdre O'Hanlon

  • 1Cork Cancer Research Centre, Mercy University Hospital and Leslie C. Quick Jr. Laboratory, University College Cork, Cork, Ireland.

Bioengineered Bugs
|April 7, 2011
PubMed

Insights

Bacteria show promise as targeted delivery vehicles for cancer gene therapy, offering a novel approach to selectively eradicate tumor cells with minimal side effects. This review explores their potential in anti-cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Cancer therapy requires specific treatments to eliminate tumor cells while sparing healthy tissues.
  • Gene and cell therapies offer potential for cancer treatment through therapeutic protein production.
  • Efficient and safe gene delivery to tumors remains a significant challenge in developing gene medicine.

Purpose of the Study:

  • To review the use of bacteria as vectors for cancer gene therapy.
  • To detail the mechanisms of action for bacterial-mediated gene delivery.
  • To summarize preclinical and clinical successes of this approach.

Main Methods:

  • Review of existing literature on bacterial vectors for cancer gene therapy.
  • Analysis of bacterial homing mechanisms to tumor sites.
  • Evaluation of intracellular gene delivery capabilities of invasive bacteria.

Main Results:

  • Bacteria naturally home to tumors upon systemic administration and replicate locally.
  • Invasive bacterial species can deliver genes intracellularly for tumor cell expression.
  • The review covers mechanisms and successes from preclinical and clinical studies.

Conclusions:

  • Bacteria represent a promising emerging vector family for targeted cancer gene therapy.
  • Bacterial vectors offer a strategy for efficient and specific delivery of therapeutic genes to tumors.
  • Further development is needed to optimize bacterial gene therapy for clinical application.
Keywords:
bactofectioncell therapygene deliverytumor

More Related Videos

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria08:11

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria

Published on: July 6, 2013

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Transduction01:16

Transduction

Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...